# VERTEX PHARMACEUTICALS INC / MA (VRTX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from VERTEX PHARMACEUTICALS INC / MA's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/VRTX/mda/fy2025/): filed 2026-02-13; accession 0000875320-26-000056 (https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/VRTX/mda/fy2024/): filed 2025-02-13; accession 0000875320-25-000053 (https://www.sec.gov/Archives/edgar/data/875320/000087532025000053/vrtx-20241231.htm)
- [FY 2023 MD&A](/company/VRTX/mda/fy2023/): filed 2024-02-15; accession 0000875320-24-000062 (https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/vrtx-20231231.htm)
- [FY 2022 MD&A](/company/VRTX/mda/fy2022/): filed 2023-02-10; accession 0000875320-23-000007 (https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/vrtx-20221231.htm)
- [FY 2021 MD&A](/company/VRTX/mda/fy2021/): filed 2022-02-09; accession 0000875320-22-000007 (https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/vrtx-20211231.htm)

Back to /company/VRTX/